Teleflex Incorporated (NYSE:TFX) Sees Significant Decrease in Short Interest
Teleflex Incorporated (NYSE:TFX) was the recipient of a large decline in short interest in the month of January. As of January 31st, there was short interest totalling 638,200 shares, a decline of 15.6% from the January 15th total of 755,900 shares. Currently, 1.4% of the company’s shares are short sold. Based on an average daily volume of 228,600 shares, the short-interest ratio is presently 2.8 days.
A number of equities analysts recently commented on TFX shares. Needham & Company LLC lifted their price target on shares of Teleflex from $408.00 to $423.00 and gave the stock a “buy” rating in a research note on Friday, January 31st. Wells Fargo & Co lifted their price target on shares of Teleflex from $415.00 to $425.00 and gave the stock an “overweight” rating in a research note on Friday, January 17th. Morgan Stanley lifted their price target on shares of Teleflex from $392.00 to $405.00 and gave the stock an “overweight” rating in a research note on Tuesday, December 17th. Barclays set a $365.00 price target on shares of Teleflex and gave the stock a “hold” rating in a research note on Friday, November 1st. Finally, UBS Group boosted their price objective on shares of Teleflex from $415.00 to $430.00 and gave the company a “buy” rating in a research report on Wednesday, December 18th. Three equities research analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $400.60.
In related news, Director Stephen K. M.D. Klasko sold 200 shares of Teleflex stock in a transaction dated Monday, January 27th. The shares were sold at an average price of $375.71, for a total transaction of $75,142.00. Following the completion of the transaction, the director now directly owns 936 shares of the company’s stock, valued at approximately $351,664.56. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, VP Cameron P. Hicks sold 1,300 shares of Teleflex stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $350.00, for a total transaction of $455,000.00. Following the transaction, the vice president now directly owns 6,106 shares of the company’s stock, valued at $2,137,100. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 6,700 shares of company stock valued at $2,342,968. 2.36% of the stock is owned by corporate insiders.
Teleflex stock traded up $4.87 during trading hours on Friday, hitting $386.65. The company had a trading volume of 175,200 shares, compared to its average volume of 174,110. The firm has a market cap of $17.44 billion, a P/E ratio of 41.05, a P/E/G ratio of 2.07 and a beta of 0.94. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.44 and a current ratio of 2.33. Teleflex has a 1 year low of $269.88 and a 1 year high of $390.21. The company has a 50-day moving average price of $378.70 and a two-hundred day moving average price of $355.89.
Teleflex Company Profile
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease.
Featured Story: P/E Growth (PEG)
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.